James Douglas explains how COVID-19 has been a significant catalyst for positive change for the healthcare sector, driving efficiencies through the system. This is yielding compelling investment opportunities – particularly in life sciences tools & services. But what are the implications of the US Presidential election for healthcare and what is the outlook for 2021?